“…The Visium platform expands the spatial resolution 5-fold beyond the first-generation 'Spatial Transcriptomics' approach (Ståhl et al, 2016) upon which it is based. While the original approach was successfully used to generate gene expression atlases and identify perturbations in transcriptional pathways for several normal and pathological human tissues, including the developing heart (Asp et al, 2018) , invasive ductal cancer (Ståhl et al, 2016) , pancreatic ductal adenocarcinoma (Moncada et al, 2018) , prostate cancer (Berglund et al, 2018) , postmortem spinal cord (Maniatis et al, 2019) and cerebellum (Gregory et al, 2020) of patients with amyotrophic lateral sclerosis (ALS), it lacked the necessary spatial resolution to resolve both individual cells and laminar structures in the human cortex.…”